APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lyophilized IVIG

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lyophilized IVIG Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchLyophilized IVIG Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyophilized IVIG Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Lyophilized IVIG Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyophilized IVIG Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyophilized IVIG Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lyophilized IVIG market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lyophilized IVIG is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lyophilized IVIG market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lyophilized IVIG market include Biotest, BPL, CBPO, CNBG, CSL, Grifols, Kedrion, LFB Group and Octapharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lyophilized IVIG market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lyophilized IVIG and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lyophilized IVIG sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lyophilized IVIG market size, projected growth trends, production technologies, key applications, and end-use industries.

Lyophilized IVIG Segment by Company

Biotest

BPL

CBPO

CNBG

CSL

Grifols

Kedrion

LFB Group

Octapharma

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

Takeda

Lyophilized IVIG Segment by Type

2.5g

1.25g

Lyophilized IVIG Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Lyophilized IVIG Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lyophilized IVIG status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lyophilized IVIG market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lyophilized IVIG significant trends, drivers, influence factors in global and regions.

6. To analyze Lyophilized IVIG competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyophilized IVIG market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyophilized IVIG and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyophilized IVIG.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lyophilized IVIG market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lyophilized IVIG industry.

Chapter 3: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lyophilized IVIG in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lyophilized IVIG Industry Trends Table 2. Lyophilized IVIG Industry Drivers Table 3. Lyophilized IVIG Industry Opportunities and Challenges Table 4. Lyophilized IVIG Industry Restraints Table 5. Global Lyophilized IVIG Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lyophilized IVIG Revenue Share by Company (2021-2026) Table 7. Global Lyophilized IVIG Sales Volume by Company (k units) & (2021-2026) Table 8. Global Lyophilized IVIG Sales Volume Share by Company (2021-2026) Table 9. Global Lyophilized IVIG Average Price (US$/unit) of Company (2021-2026) Table 10. Global Lyophilized IVIG Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lyophilized IVIG Key Company Manufacturing Base & Headquarters Table 12. Global Lyophilized IVIG Company, Product Type & Application Table 13. Global Lyophilized IVIG Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lyophilized IVIG by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 2.5g Table 18. Significant Companies of 1.25g Table 19. Global Lyophilized IVIG Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Lyophilized IVIG Sales Volume by Type (2021-2026) & (k units) Table 21. Global Lyophilized IVIG Sales Volume by Type (2027-2032) & (k units) Table 22. Global Lyophilized IVIG Sales Volume Share by Type (2021-2026) Table 23. Global Lyophilized IVIG Sales Volume Share by Type (2027-2032) Table 24. Global Lyophilized IVIG Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lyophilized IVIG Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lyophilized IVIG Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lyophilized IVIG Sales Value Share by Type (2021-2026) Table 28. Global Lyophilized IVIG Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Autoimmune Disease Table 30. Significant Companies of Immunodeficiency Table 31. Significant Companies of Acute Infection Table 32. Global Lyophilized IVIG Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Lyophilized IVIG Sales Volume by Application (2021-2026) & (k units) Table 34. Global Lyophilized IVIG Sales Volume by Application (2027-2032) & (k units) Table 35. Global Lyophilized IVIG Sales Volume Share by Application (2021-2026) Table 36. Global Lyophilized IVIG Sales Volume Share by Application (2027-2032) Table 37. Global Lyophilized IVIG Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lyophilized IVIG Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lyophilized IVIG Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lyophilized IVIG Sales Value Share by Application (2021-2026) Table 41. Global Lyophilized IVIG Sales Value Share by Application (2027-2032) Table 42. Global Lyophilized IVIG Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Lyophilized IVIG Sales by Region (2021-2026) & (k units) Table 44. Global Lyophilized IVIG Sales Market Share by Region (2021-2026) Table 45. Global Lyophilized IVIG Sales by Region (2027-2032) & (k units) Table 46. Global Lyophilized IVIG Sales Market Share by Region (2027-2032) Table 47. Global Lyophilized IVIG Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lyophilized IVIG Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lyophilized IVIG Sales Value Share by Region (2021-2026) Table 50. Global Lyophilized IVIG Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lyophilized IVIG Sales Value Share by Region (2027-2032) Table 52. Global Lyophilized IVIG Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Lyophilized IVIG Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Lyophilized IVIG Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lyophilized IVIG Sales by Country (2021-2026) & (k units) Table 57. Global Lyophilized IVIG Sales Market Share by Country (2021-2026) Table 58. Global Lyophilized IVIG Sales by Country (2027-2032) & (k units) Table 59. Global Lyophilized IVIG Sales Market Share by Country (2027-2032) Table 60. Global Lyophilized IVIG Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lyophilized IVIG Sales Value Market Share by Country (2021-2026) Table 62. Global Lyophilized IVIG Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lyophilized IVIG Sales Value Market Share by Country (2027-2032) Table 64. Biotest Company Information Table 65. Biotest Business Overview Table 66. Biotest Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Biotest Lyophilized IVIG Product Portfolio Table 68. Biotest Recent Development Table 69. BPL Company Information Table 70. BPL Business Overview Table 71. BPL Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. BPL Lyophilized IVIG Product Portfolio Table 73. BPL Recent Development Table 74. CBPO Company Information Table 75. CBPO Business Overview Table 76. CBPO Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. CBPO Lyophilized IVIG Product Portfolio Table 78. CBPO Recent Development Table 79. CNBG Company Information Table 80. CNBG Business Overview Table 81. CNBG Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. CNBG Lyophilized IVIG Product Portfolio Table 83. CNBG Recent Development Table 84. CSL Company Information Table 85. CSL Business Overview Table 86. CSL Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. CSL Lyophilized IVIG Product Portfolio Table 88. CSL Recent Development Table 89. Grifols Company Information Table 90. Grifols Business Overview Table 91. Grifols Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Grifols Lyophilized IVIG Product Portfolio Table 93. Grifols Recent Development Table 94. Kedrion Company Information Table 95. Kedrion Business Overview Table 96. Kedrion Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Kedrion Lyophilized IVIG Product Portfolio Table 98. Kedrion Recent Development Table 99. LFB Group Company Information Table 100. LFB Group Business Overview Table 101. LFB Group Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. LFB Group Lyophilized IVIG Product Portfolio Table 103. LFB Group Recent Development Table 104. Octapharma Company Information Table 105. Octapharma Business Overview Table 106. Octapharma Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Octapharma Lyophilized IVIG Product Portfolio Table 108. Octapharma Recent Development Table 109. Hualan Bio Company Information Table 110. Hualan Bio Business Overview Table 111. Hualan Bio Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Hualan Bio Lyophilized IVIG Product Portfolio Table 113. Hualan Bio Recent Development Table 114. Shanghai RAAS Company Information Table 115. Shanghai RAAS Business Overview Table 116. Shanghai RAAS Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Shanghai RAAS Lyophilized IVIG Product Portfolio Table 118. Shanghai RAAS Recent Development Table 119. Sichuan Yuanda Shuyang Company Information Table 120. Sichuan Yuanda Shuyang Business Overview Table 121. Sichuan Yuanda Shuyang Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio Table 123. Sichuan Yuanda Shuyang Recent Development Table 124. Takeda Company Information Table 125. Takeda Business Overview Table 126. Takeda Lyophilized IVIG Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Takeda Lyophilized IVIG Product Portfolio Table 128. Takeda Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Lyophilized IVIG Distributors List Table 132. Lyophilized IVIG Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Lyophilized IVIG Product Image Figure 2. Global Lyophilized IVIG Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lyophilized IVIG Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lyophilized IVIG Sales (2021-2032) & (k units) Figure 5. Global Lyophilized IVIG Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Lyophilized IVIG Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 2.5g Image Figure 10. 1.25g Image Figure 11. Global Lyophilized IVIG Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Lyophilized IVIG Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lyophilized IVIG Sales Volume Share by Type (2021-2032) Figure 14. Global Lyophilized IVIG Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lyophilized IVIG Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lyophilized IVIG Sales Value Share by Type (2021-2032) Figure 17. Autoimmune Disease Image Figure 18. Immunodeficiency Image Figure 19. Acute Infection Image Figure 20. Global Lyophilized IVIG Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Lyophilized IVIG Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lyophilized IVIG Sales Volume Share by Application (2021-2032) Figure 23. Global Lyophilized IVIG Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lyophilized IVIG Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lyophilized IVIG Sales Value Share by Application (2021-2032) Figure 26. Global Lyophilized IVIG Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Lyophilized IVIG Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lyophilized IVIG Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lyophilized IVIG Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lyophilized IVIG Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lyophilized IVIG Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lyophilized IVIG Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lyophilized IVIG Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lyophilized IVIG Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lyophilized IVIG Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lyophilized IVIG Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lyophilized IVIG Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lyophilized IVIG Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lyophilized IVIG Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lyophilized IVIG Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lyophilized IVIG Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lyophilized IVIG Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5g
  • 1.25g
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Biotest
  • BPL
  • CBPO
  • CNBG
  • CSL
  • Grifols
  • Kedrion
  • LFB Group
  • Octapharma
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lyophilized IVIG Sales Value (2021-2032)
  4. 1.2.2 Global Lyophilized IVIG Sales Volume (2021-2032)
  5. 1.2.3 Global Lyophilized IVIG Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lyophilized IVIG Market Dynamics
  1. 2.1 Lyophilized IVIG Industry Trends
  2. 2.2 Lyophilized IVIG Industry Drivers
  3. 2.3 Lyophilized IVIG Industry Opportunities and Challenges
  4. 2.4 Lyophilized IVIG Industry Restraints
3 Lyophilized IVIG Market by Company
  1. 3.1 Global Lyophilized IVIG Company Revenue Ranking in 2025
  2. 3.2 Global Lyophilized IVIG Revenue by Company (2021-2026)
  3. 3.3 Global Lyophilized IVIG Sales Volume by Company (2021-2026)
  4. 3.4 Global Lyophilized IVIG Average Price by Company (2021-2026)
  5. 3.5 Global Lyophilized IVIG Company Ranking (2024-2026)
  6. 3.6 Global Lyophilized IVIG Company Manufacturing Base and Headquarters
  7. 3.7 Global Lyophilized IVIG Company Product Type and Application
  8. 3.8 Global Lyophilized IVIG Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lyophilized IVIG Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lyophilized IVIG Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lyophilized IVIG Market by Type
  1. 4.1 Lyophilized IVIG Type Introduction
  2. 4.1.1 2.5g
  3. 4.1.2 1.25g
  4. 4.2 Global Lyophilized IVIG Sales Volume by Type
  5. 4.2.1 Global Lyophilized IVIG Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lyophilized IVIG Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lyophilized IVIG Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lyophilized IVIG Sales Value by Type
  9. 4.3.1 Global Lyophilized IVIG Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lyophilized IVIG Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lyophilized IVIG Sales Value Share by Type (2021-2032)
5 Lyophilized IVIG Market by Application
  1. 5.1 Lyophilized IVIG Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Lyophilized IVIG Sales Volume by Application
  6. 5.2.1 Global Lyophilized IVIG Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lyophilized IVIG Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lyophilized IVIG Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lyophilized IVIG Sales Value by Application
  10. 5.3.1 Global Lyophilized IVIG Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lyophilized IVIG Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lyophilized IVIG Sales Value Share by Application (2021-2032)
6 Lyophilized IVIG Regional Sales and Value Analysis
  1. 6.1 Global Lyophilized IVIG Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lyophilized IVIG Sales by Region (2021-2032)
  3. 6.2.1 Global Lyophilized IVIG Sales by Region: 2021-2026
  4. 6.2.2 Global Lyophilized IVIG Sales by Region (2027-2032)
  5. 6.3 Global Lyophilized IVIG Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lyophilized IVIG Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lyophilized IVIG Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lyophilized IVIG Sales Value by Region (2027-2032)
  9. 6.5 Global Lyophilized IVIG Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lyophilized IVIG Sales Value (2021-2032)
  12. 6.6.2 North America Lyophilized IVIG Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lyophilized IVIG Sales Value (2021-2032)
  15. 6.7.2 Europe Lyophilized IVIG Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lyophilized IVIG Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lyophilized IVIG Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lyophilized IVIG Sales Value (2021-2032)
  21. 6.9.2 South America Lyophilized IVIG Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lyophilized IVIG Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lyophilized IVIG Sales Value Share by Country, 2025 VS 2032
7 Lyophilized IVIG Country-level Sales and Value Analysis
  1. 7.1 Global Lyophilized IVIG Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lyophilized IVIG Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lyophilized IVIG Sales by Country (2021-2032)
  4. 7.3.1 Global Lyophilized IVIG Sales by Country (2021-2026)
  5. 7.3.2 Global Lyophilized IVIG Sales by Country (2027-2032)
  6. 7.4 Global Lyophilized IVIG Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lyophilized IVIG Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lyophilized IVIG Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lyophilized IVIG Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lyophilized IVIG Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lyophilized IVIG Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biotest
  2. 8.1.1 Biotest Company Information
  3. 8.1.2 Biotest Business Overview
  4. 8.1.3 Biotest Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biotest Lyophilized IVIG Product Portfolio
  6. 8.1.5 Biotest Recent Developments
  7. 8.2 BPL
  8. 8.2.1 BPL Company Information
  9. 8.2.2 BPL Business Overview
  10. 8.2.3 BPL Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BPL Lyophilized IVIG Product Portfolio
  12. 8.2.5 BPL Recent Developments
  13. 8.3 CBPO
  14. 8.3.1 CBPO Company Information
  15. 8.3.2 CBPO Business Overview
  16. 8.3.3 CBPO Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CBPO Lyophilized IVIG Product Portfolio
  18. 8.3.5 CBPO Recent Developments
  19. 8.4 CNBG
  20. 8.4.1 CNBG Company Information
  21. 8.4.2 CNBG Business Overview
  22. 8.4.3 CNBG Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CNBG Lyophilized IVIG Product Portfolio
  24. 8.4.5 CNBG Recent Developments
  25. 8.5 CSL
  26. 8.5.1 CSL Company Information
  27. 8.5.2 CSL Business Overview
  28. 8.5.3 CSL Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CSL Lyophilized IVIG Product Portfolio
  30. 8.5.5 CSL Recent Developments
  31. 8.6 Grifols
  32. 8.6.1 Grifols Company Information
  33. 8.6.2 Grifols Business Overview
  34. 8.6.3 Grifols Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Grifols Lyophilized IVIG Product Portfolio
  36. 8.6.5 Grifols Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion Lyophilized IVIG Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 LFB Group
  44. 8.8.1 LFB Group Company Information
  45. 8.8.2 LFB Group Business Overview
  46. 8.8.3 LFB Group Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LFB Group Lyophilized IVIG Product Portfolio
  48. 8.8.5 LFB Group Recent Developments
  49. 8.9 Octapharma
  50. 8.9.1 Octapharma Company Information
  51. 8.9.2 Octapharma Business Overview
  52. 8.9.3 Octapharma Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Octapharma Lyophilized IVIG Product Portfolio
  54. 8.9.5 Octapharma Recent Developments
  55. 8.10 Hualan Bio
  56. 8.10.1 Hualan Bio Company Information
  57. 8.10.2 Hualan Bio Business Overview
  58. 8.10.3 Hualan Bio Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Bio Lyophilized IVIG Product Portfolio
  60. 8.10.5 Hualan Bio Recent Developments
  61. 8.11 Shanghai RAAS
  62. 8.11.1 Shanghai RAAS Company Information
  63. 8.11.2 Shanghai RAAS Business Overview
  64. 8.11.3 Shanghai RAAS Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai RAAS Lyophilized IVIG Product Portfolio
  66. 8.11.5 Shanghai RAAS Recent Developments
  67. 8.12 Sichuan Yuanda Shuyang
  68. 8.12.1 Sichuan Yuanda Shuyang Company Information
  69. 8.12.2 Sichuan Yuanda Shuyang Business Overview
  70. 8.12.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio
  72. 8.12.5 Sichuan Yuanda Shuyang Recent Developments
  73. 8.13 Takeda
  74. 8.13.1 Takeda Company Information
  75. 8.13.2 Takeda Business Overview
  76. 8.13.3 Takeda Lyophilized IVIG Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Takeda Lyophilized IVIG Product Portfolio
  78. 8.13.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lyophilized IVIG Value Chain Analysis
  2. 9.1.1 Lyophilized IVIG Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lyophilized IVIG Sales Mode & Process
  6. 9.2 Lyophilized IVIG Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lyophilized IVIG Distributors
  9. 9.2.3 Lyophilized IVIG Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst